ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vaccine (Include COVID-19) Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-35G13681
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Vaccine Include COVID 19 Market Research Report 2023
BUY CHAPTERS

Global Vaccine (Include COVID-19) Market Research Report 2025

Code: QYRE-Auto-35G13681
Report
May 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
CSL Limited
GSK
Viatris
Astrazeneca plc
Hualan Bio
Changchun Institute of Biological
KM Biologics
Pfizer Inc
Merck
Zhejiang Pukang
Walvax Biotechnology
Bharat Biotech
Serum Institute
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
LG Life Sciences
Sinovac

Vaccine (Include COVID-19) Market Size

The global market for Vaccine (Include COVID-19) was valued at US$ 59960 million in the year 2024 and is projected to reach a revised size of US$ 76800 million by 2031, growing at a CAGR of 3.7% during the forecast period.

Vaccine (Include COVID-19) Market

Vaccine (Include COVID-19) Market

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Vaccine (Include COVID-19), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine (Include COVID-19).
The Vaccine (Include COVID-19) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vaccine (Include COVID-19) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine (Include COVID-19) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Vaccine (Include COVID-19) Market Report

Report Metric Details
Report Name Vaccine (Include COVID-19) Market
Accounted market size in year US$ 59960 million
Forecasted market size in 2031 US$ 76800 million
CAGR 3.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Public
  • Private
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, KM Biologics, Pfizer, Merck, Zhejiang Pukang, Walvax Biotechnology, Bharat Biotech, Serum Institute, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals, LG Life Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Vaccine (Include COVID-19) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Vaccine (Include COVID-19) Market growing?

Ans: The Vaccine (Include COVID-19) Market witnessing a CAGR of 3.7% during the forecast period 2025-2031.

What is the Vaccine (Include COVID-19) Market size in 2031?

Ans: The Vaccine (Include COVID-19) Market size in 2031 will be US$ 76800 million.

Who are the main players in the Vaccine (Include COVID-19) Market report?

Ans: The main players in the Vaccine (Include COVID-19) Market are Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, KM Biologics, Pfizer, Merck, Zhejiang Pukang, Walvax Biotechnology, Bharat Biotech, Serum Institute, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals, LG Life Sciences

What are the Application segmentation covered in the Vaccine (Include COVID-19) Market report?

Ans: The Applications covered in the Vaccine (Include COVID-19) Market report are Public, Private

What are the Type segmentation covered in the Vaccine (Include COVID-19) Market report?

Ans: The Types covered in the Vaccine (Include COVID-19) Market report are Inactivated Vaccine, Attenuated Vaccine, mRNA, Other

Recommended Reports

COVID-19 Vaccines & Drugs

Inactivated & Viral Vaccines

Vaccine Devices & Manufacturing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccine (Include COVID-19) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Inactivated Vaccine
1.2.3 Attenuated Vaccine
1.2.4 mRNA
1.2.5 Other
1.3 Market by Application
1.3.1 Global Vaccine (Include COVID-19) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Public
1.3.3 Private
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vaccine (Include COVID-19) Market Perspective (2020-2031)
2.2 Global Vaccine (Include COVID-19) Growth Trends by Region
2.2.1 Global Vaccine (Include COVID-19) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Vaccine (Include COVID-19) Historic Market Size by Region (2020-2025)
2.2.3 Vaccine (Include COVID-19) Forecasted Market Size by Region (2026-2031)
2.3 Vaccine (Include COVID-19) Market Dynamics
2.3.1 Vaccine (Include COVID-19) Industry Trends
2.3.2 Vaccine (Include COVID-19) Market Drivers
2.3.3 Vaccine (Include COVID-19) Market Challenges
2.3.4 Vaccine (Include COVID-19) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaccine (Include COVID-19) Players by Revenue
3.1.1 Global Top Vaccine (Include COVID-19) Players by Revenue (2020-2025)
3.1.2 Global Vaccine (Include COVID-19) Revenue Market Share by Players (2020-2025)
3.2 Global Vaccine (Include COVID-19) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Vaccine (Include COVID-19) Revenue
3.4 Global Vaccine (Include COVID-19) Market Concentration Ratio
3.4.1 Global Vaccine (Include COVID-19) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccine (Include COVID-19) Revenue in 2024
3.5 Global Key Players of Vaccine (Include COVID-19) Head office and Area Served
3.6 Global Key Players of Vaccine (Include COVID-19), Product and Application
3.7 Global Key Players of Vaccine (Include COVID-19), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccine (Include COVID-19) Breakdown Data by Type
4.1 Global Vaccine (Include COVID-19) Historic Market Size by Type (2020-2025)
4.2 Global Vaccine (Include COVID-19) Forecasted Market Size by Type (2026-2031)
5 Vaccine (Include COVID-19) Breakdown Data by Application
5.1 Global Vaccine (Include COVID-19) Historic Market Size by Application (2020-2025)
5.2 Global Vaccine (Include COVID-19) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Vaccine (Include COVID-19) Market Size (2020-2031)
6.2 North America Vaccine (Include COVID-19) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Vaccine (Include COVID-19) Market Size by Country (2020-2025)
6.4 North America Vaccine (Include COVID-19) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vaccine (Include COVID-19) Market Size (2020-2031)
7.2 Europe Vaccine (Include COVID-19) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Vaccine (Include COVID-19) Market Size by Country (2020-2025)
7.4 Europe Vaccine (Include COVID-19) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vaccine (Include COVID-19) Market Size (2020-2031)
8.2 Asia-Pacific Vaccine (Include COVID-19) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Vaccine (Include COVID-19) Market Size by Region (2020-2025)
8.4 Asia-Pacific Vaccine (Include COVID-19) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vaccine (Include COVID-19) Market Size (2020-2031)
9.2 Latin America Vaccine (Include COVID-19) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Vaccine (Include COVID-19) Market Size by Country (2020-2025)
9.4 Latin America Vaccine (Include COVID-19) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaccine (Include COVID-19) Market Size (2020-2031)
10.2 Middle East & Africa Vaccine (Include COVID-19) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Vaccine (Include COVID-19) Market Size by Country (2020-2025)
10.4 Middle East & Africa Vaccine (Include COVID-19) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Vaccine (Include COVID-19) Introduction
11.1.4 Sanofi Revenue in Vaccine (Include COVID-19) Business (2020-2025)
11.1.5 Sanofi Recent Development
11.2 CSL
11.2.1 CSL Company Details
11.2.2 CSL Business Overview
11.2.3 CSL Vaccine (Include COVID-19) Introduction
11.2.4 CSL Revenue in Vaccine (Include COVID-19) Business (2020-2025)
11.2.5 CSL Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Vaccine (Include COVID-19) Introduction
11.3.4 GSK Revenue in Vaccine (Include COVID-19) Business (2020-2025)
11.3.5 GSK Recent Development
11.4 Viatris
11.4.1 Viatris Company Details
11.4.2 Viatris Business Overview
11.4.3 Viatris Vaccine (Include COVID-19) Introduction
11.4.4 Viatris Revenue in Vaccine (Include COVID-19) Business (2020-2025)
11.4.5 Viatris Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Vaccine (Include COVID-19) Introduction
11.5.4 AstraZeneca Revenue in Vaccine (Include COVID-19) Business (2020-2025)
11.5.5 AstraZeneca Recent Development
11.6 Hualan Bio
11.6.1 Hualan Bio Company Details
11.6.2 Hualan Bio Business Overview
11.6.3 Hualan Bio Vaccine (Include COVID-19) Introduction
11.6.4 Hualan Bio Revenue in Vaccine (Include COVID-19) Business (2020-2025)
11.6.5 Hualan Bio Recent Development
11.7 Changchun Institute of Biological
11.7.1 Changchun Institute of Biological Company Details
11.7.2 Changchun Institute of Biological Business Overview
11.7.3 Changchun Institute of Biological Vaccine (Include COVID-19) Introduction
11.7.4 Changchun Institute of Biological Revenue in Vaccine (Include COVID-19) Business (2020-2025)
11.7.5 Changchun Institute of Biological Recent Development
11.8 Sinovac
11.8.1 Sinovac Company Details
11.8.2 Sinovac Business Overview
11.8.3 Sinovac Vaccine (Include COVID-19) Introduction
11.8.4 Sinovac Revenue in Vaccine (Include COVID-19) Business (2020-2025)
11.8.5 Sinovac Recent Development
11.9 KM Biologics
11.9.1 KM Biologics Company Details
11.9.2 KM Biologics Business Overview
11.9.3 KM Biologics Vaccine (Include COVID-19) Introduction
11.9.4 KM Biologics Revenue in Vaccine (Include COVID-19) Business (2020-2025)
11.9.5 KM Biologics Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Vaccine (Include COVID-19) Introduction
11.10.4 Pfizer Revenue in Vaccine (Include COVID-19) Business (2020-2025)
11.10.5 Pfizer Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Vaccine (Include COVID-19) Introduction
11.11.4 Merck Revenue in Vaccine (Include COVID-19) Business (2020-2025)
11.11.5 Merck Recent Development
11.12 Sinovac
11.12.1 Sinovac Company Details
11.12.2 Sinovac Business Overview
11.12.3 Sinovac Vaccine (Include COVID-19) Introduction
11.12.4 Sinovac Revenue in Vaccine (Include COVID-19) Business (2020-2025)
11.12.5 Sinovac Recent Development
11.13 Zhejiang Pukang
11.13.1 Zhejiang Pukang Company Details
11.13.2 Zhejiang Pukang Business Overview
11.13.3 Zhejiang Pukang Vaccine (Include COVID-19) Introduction
11.13.4 Zhejiang Pukang Revenue in Vaccine (Include COVID-19) Business (2020-2025)
11.13.5 Zhejiang Pukang Recent Development
11.14 Walvax Biotechnology
11.14.1 Walvax Biotechnology Company Details
11.14.2 Walvax Biotechnology Business Overview
11.14.3 Walvax Biotechnology Vaccine (Include COVID-19) Introduction
11.14.4 Walvax Biotechnology Revenue in Vaccine (Include COVID-19) Business (2020-2025)
11.14.5 Walvax Biotechnology Recent Development
11.15 Bharat Biotech
11.15.1 Bharat Biotech Company Details
11.15.2 Bharat Biotech Business Overview
11.15.3 Bharat Biotech Vaccine (Include COVID-19) Introduction
11.15.4 Bharat Biotech Revenue in Vaccine (Include COVID-19) Business (2020-2025)
11.15.5 Bharat Biotech Recent Development
11.16 Serum Institute
11.16.1 Serum Institute Company Details
11.16.2 Serum Institute Business Overview
11.16.3 Serum Institute Vaccine (Include COVID-19) Introduction
11.16.4 Serum Institute Revenue in Vaccine (Include COVID-19) Business (2020-2025)
11.16.5 Serum Institute Recent Development
11.17 Panacea Biotec Ltd
11.17.1 Panacea Biotec Ltd Company Details
11.17.2 Panacea Biotec Ltd Business Overview
11.17.3 Panacea Biotec Ltd Vaccine (Include COVID-19) Introduction
11.17.4 Panacea Biotec Ltd Revenue in Vaccine (Include COVID-19) Business (2020-2025)
11.17.5 Panacea Biotec Ltd Recent Development
11.18 Bio-Med
11.18.1 Bio-Med Company Details
11.18.2 Bio-Med Business Overview
11.18.3 Bio-Med Vaccine (Include COVID-19) Introduction
11.18.4 Bio-Med Revenue in Vaccine (Include COVID-19) Business (2020-2025)
11.18.5 Bio-Med Recent Development
11.19 Halfkin Bio-Pharmaceuticals
11.19.1 Halfkin Bio-Pharmaceuticals Company Details
11.19.2 Halfkin Bio-Pharmaceuticals Business Overview
11.19.3 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Introduction
11.19.4 Halfkin Bio-Pharmaceuticals Revenue in Vaccine (Include COVID-19) Business (2020-2025)
11.19.5 Halfkin Bio-Pharmaceuticals Recent Development
11.20 LG Life Sciences
11.20.1 LG Life Sciences Company Details
11.20.2 LG Life Sciences Business Overview
11.20.3 LG Life Sciences Vaccine (Include COVID-19) Introduction
11.20.4 LG Life Sciences Revenue in Vaccine (Include COVID-19) Business (2020-2025)
11.20.5 LG Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Sanofi
CSL Limited
GSK
Viatris
Astrazeneca plc
Hualan Bio
Changchun Institute of Biological
KM Biologics
Pfizer Inc
Merck
Zhejiang Pukang
Walvax Biotechnology
Bharat Biotech
Serum Institute
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
LG Life Sciences
Sinovac
List of Tables
 Table 1. Global Vaccine (Include COVID-19) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Inactivated Vaccine
 Table 3. Key Players of Attenuated Vaccine
 Table 4. Key Players of mRNA
 Table 5. Key Players of Other
 Table 6. Global Vaccine (Include COVID-19) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Vaccine (Include COVID-19) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Vaccine (Include COVID-19) Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Vaccine (Include COVID-19) Market Share by Region (2020-2025)
 Table 10. Global Vaccine (Include COVID-19) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Vaccine (Include COVID-19) Market Share by Region (2026-2031)
 Table 12. Vaccine (Include COVID-19) Market Trends
 Table 13. Vaccine (Include COVID-19) Market Drivers
 Table 14. Vaccine (Include COVID-19) Market Challenges
 Table 15. Vaccine (Include COVID-19) Market Restraints
 Table 16. Global Vaccine (Include COVID-19) Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Vaccine (Include COVID-19) Market Share by Players (2020-2025)
 Table 18. Global Top Vaccine (Include COVID-19) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine (Include COVID-19) as of 2024)
 Table 19. Ranking of Global Top Vaccine (Include COVID-19) Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Vaccine (Include COVID-19) Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Vaccine (Include COVID-19), Headquarters and Area Served
 Table 22. Global Key Players of Vaccine (Include COVID-19), Product and Application
 Table 23. Global Key Players of Vaccine (Include COVID-19), Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Vaccine (Include COVID-19) Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Vaccine (Include COVID-19) Revenue Market Share by Type (2020-2025)
 Table 27. Global Vaccine (Include COVID-19) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Vaccine (Include COVID-19) Revenue Market Share by Type (2026-2031)
 Table 29. Global Vaccine (Include COVID-19) Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Vaccine (Include COVID-19) Revenue Market Share by Application (2020-2025)
 Table 31. Global Vaccine (Include COVID-19) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Vaccine (Include COVID-19) Revenue Market Share by Application (2026-2031)
 Table 33. North America Vaccine (Include COVID-19) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Vaccine (Include COVID-19) Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Vaccine (Include COVID-19) Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Vaccine (Include COVID-19) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Vaccine (Include COVID-19) Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Vaccine (Include COVID-19) Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Vaccine (Include COVID-19) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Vaccine (Include COVID-19) Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Vaccine (Include COVID-19) Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Vaccine (Include COVID-19) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Vaccine (Include COVID-19) Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Vaccine (Include COVID-19) Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Vaccine (Include COVID-19) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Vaccine (Include COVID-19) Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Vaccine (Include COVID-19) Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Sanofi Company Details
 Table 49. Sanofi Business Overview
 Table 50. Sanofi Vaccine (Include COVID-19) Product
 Table 51. Sanofi Revenue in Vaccine (Include COVID-19) Business (2020-2025) & (US$ Million)
 Table 52. Sanofi Recent Development
 Table 53. CSL Company Details
 Table 54. CSL Business Overview
 Table 55. CSL Vaccine (Include COVID-19) Product
 Table 56. CSL Revenue in Vaccine (Include COVID-19) Business (2020-2025) & (US$ Million)
 Table 57. CSL Recent Development
 Table 58. GSK Company Details
 Table 59. GSK Business Overview
 Table 60. GSK Vaccine (Include COVID-19) Product
 Table 61. GSK Revenue in Vaccine (Include COVID-19) Business (2020-2025) & (US$ Million)
 Table 62. GSK Recent Development
 Table 63. Viatris Company Details
 Table 64. Viatris Business Overview
 Table 65. Viatris Vaccine (Include COVID-19) Product
 Table 66. Viatris Revenue in Vaccine (Include COVID-19) Business (2020-2025) & (US$ Million)
 Table 67. Viatris Recent Development
 Table 68. AstraZeneca Company Details
 Table 69. AstraZeneca Business Overview
 Table 70. AstraZeneca Vaccine (Include COVID-19) Product
 Table 71. AstraZeneca Revenue in Vaccine (Include COVID-19) Business (2020-2025) & (US$ Million)
 Table 72. AstraZeneca Recent Development
 Table 73. Hualan Bio Company Details
 Table 74. Hualan Bio Business Overview
 Table 75. Hualan Bio Vaccine (Include COVID-19) Product
 Table 76. Hualan Bio Revenue in Vaccine (Include COVID-19) Business (2020-2025) & (US$ Million)
 Table 77. Hualan Bio Recent Development
 Table 78. Changchun Institute of Biological Company Details
 Table 79. Changchun Institute of Biological Business Overview
 Table 80. Changchun Institute of Biological Vaccine (Include COVID-19) Product
 Table 81. Changchun Institute of Biological Revenue in Vaccine (Include COVID-19) Business (2020-2025) & (US$ Million)
 Table 82. Changchun Institute of Biological Recent Development
 Table 83. Sinovac Company Details
 Table 84. Sinovac Business Overview
 Table 85. Sinovac Vaccine (Include COVID-19) Product
 Table 86. Sinovac Revenue in Vaccine (Include COVID-19) Business (2020-2025) & (US$ Million)
 Table 87. Sinovac Recent Development
 Table 88. KM Biologics Company Details
 Table 89. KM Biologics Business Overview
 Table 90. KM Biologics Vaccine (Include COVID-19) Product
 Table 91. KM Biologics Revenue in Vaccine (Include COVID-19) Business (2020-2025) & (US$ Million)
 Table 92. KM Biologics Recent Development
 Table 93. Pfizer Company Details
 Table 94. Pfizer Business Overview
 Table 95. Pfizer Vaccine (Include COVID-19) Product
 Table 96. Pfizer Revenue in Vaccine (Include COVID-19) Business (2020-2025) & (US$ Million)
 Table 97. Pfizer Recent Development
 Table 98. Merck Company Details
 Table 99. Merck Business Overview
 Table 100. Merck Vaccine (Include COVID-19) Product
 Table 101. Merck Revenue in Vaccine (Include COVID-19) Business (2020-2025) & (US$ Million)
 Table 102. Merck Recent Development
 Table 103. Sinovac Company Details
 Table 104. Sinovac Business Overview
 Table 105. Sinovac Vaccine (Include COVID-19) Product
 Table 106. Sinovac Revenue in Vaccine (Include COVID-19) Business (2020-2025) & (US$ Million)
 Table 107. Sinovac Recent Development
 Table 108. Zhejiang Pukang Company Details
 Table 109. Zhejiang Pukang Business Overview
 Table 110. Zhejiang Pukang Vaccine (Include COVID-19) Product
 Table 111. Zhejiang Pukang Revenue in Vaccine (Include COVID-19) Business (2020-2025) & (US$ Million)
 Table 112. Zhejiang Pukang Recent Development
 Table 113. Walvax Biotechnology Company Details
 Table 114. Walvax Biotechnology Business Overview
 Table 115. Walvax Biotechnology Vaccine (Include COVID-19) Product
 Table 116. Walvax Biotechnology Revenue in Vaccine (Include COVID-19) Business (2020-2025) & (US$ Million)
 Table 117. Walvax Biotechnology Recent Development
 Table 118. Bharat Biotech Company Details
 Table 119. Bharat Biotech Business Overview
 Table 120. Bharat Biotech Vaccine (Include COVID-19) Product
 Table 121. Bharat Biotech Revenue in Vaccine (Include COVID-19) Business (2020-2025) & (US$ Million)
 Table 122. Bharat Biotech Recent Development
 Table 123. Serum Institute Company Details
 Table 124. Serum Institute Business Overview
 Table 125. Serum Institute Vaccine (Include COVID-19) Product
 Table 126. Serum Institute Revenue in Vaccine (Include COVID-19) Business (2020-2025) & (US$ Million)
 Table 127. Serum Institute Recent Development
 Table 128. Panacea Biotec Ltd Company Details
 Table 129. Panacea Biotec Ltd Business Overview
 Table 130. Panacea Biotec Ltd Vaccine (Include COVID-19) Product
 Table 131. Panacea Biotec Ltd Revenue in Vaccine (Include COVID-19) Business (2020-2025) & (US$ Million)
 Table 132. Panacea Biotec Ltd Recent Development
 Table 133. Bio-Med Company Details
 Table 134. Bio-Med Business Overview
 Table 135. Bio-Med Vaccine (Include COVID-19) Product
 Table 136. Bio-Med Revenue in Vaccine (Include COVID-19) Business (2020-2025) & (US$ Million)
 Table 137. Bio-Med Recent Development
 Table 138. Halfkin Bio-Pharmaceuticals Company Details
 Table 139. Halfkin Bio-Pharmaceuticals Business Overview
 Table 140. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product
 Table 141. Halfkin Bio-Pharmaceuticals Revenue in Vaccine (Include COVID-19) Business (2020-2025) & (US$ Million)
 Table 142. Halfkin Bio-Pharmaceuticals Recent Development
 Table 143. LG Life Sciences Company Details
 Table 144. LG Life Sciences Business Overview
 Table 145. LG Life Sciences Vaccine (Include COVID-19) Product
 Table 146. LG Life Sciences Revenue in Vaccine (Include COVID-19) Business (2020-2025) & (US$ Million)
 Table 147. LG Life Sciences Recent Development
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Vaccine (Include COVID-19) Picture
 Figure 2. Global Vaccine (Include COVID-19) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Vaccine (Include COVID-19) Market Share by Type: 2024 VS 2031
 Figure 4. Inactivated Vaccine Features
 Figure 5. Attenuated Vaccine Features
 Figure 6. mRNA Features
 Figure 7. Other Features
 Figure 8. Global Vaccine (Include COVID-19) Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Vaccine (Include COVID-19) Market Share by Application: 2024 VS 2031
 Figure 10. Public Case Studies
 Figure 11. Private Case Studies
 Figure 12. Vaccine (Include COVID-19) Report Years Considered
 Figure 13. Global Vaccine (Include COVID-19) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Vaccine (Include COVID-19) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Vaccine (Include COVID-19) Market Share by Region: 2024 VS 2031
 Figure 16. Global Vaccine (Include COVID-19) Market Share by Players in 2024
 Figure 17. Global Top Vaccine (Include COVID-19) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine (Include COVID-19) as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Vaccine (Include COVID-19) Revenue in 2024
 Figure 19. North America Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Vaccine (Include COVID-19) Market Share by Country (2020-2031)
 Figure 21. United States Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Vaccine (Include COVID-19) Market Share by Country (2020-2031)
 Figure 25. Germany Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Vaccine (Include COVID-19) Market Share by Region (2020-2031)
 Figure 33. China Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Vaccine (Include COVID-19) Market Share by Country (2020-2031)
 Figure 41. Mexico Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Vaccine (Include COVID-19) Market Share by Country (2020-2031)
 Figure 45. Turkey Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Vaccine (Include COVID-19) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Sanofi Revenue Growth Rate in Vaccine (Include COVID-19) Business (2020-2025)
 Figure 49. CSL Revenue Growth Rate in Vaccine (Include COVID-19) Business (2020-2025)
 Figure 50. GSK Revenue Growth Rate in Vaccine (Include COVID-19) Business (2020-2025)
 Figure 51. Viatris Revenue Growth Rate in Vaccine (Include COVID-19) Business (2020-2025)
 Figure 52. AstraZeneca Revenue Growth Rate in Vaccine (Include COVID-19) Business (2020-2025)
 Figure 53. Hualan Bio Revenue Growth Rate in Vaccine (Include COVID-19) Business (2020-2025)
 Figure 54. Changchun Institute of Biological Revenue Growth Rate in Vaccine (Include COVID-19) Business (2020-2025)
 Figure 55. Sinovac Revenue Growth Rate in Vaccine (Include COVID-19) Business (2020-2025)
 Figure 56. KM Biologics Revenue Growth Rate in Vaccine (Include COVID-19) Business (2020-2025)
 Figure 57. Pfizer Revenue Growth Rate in Vaccine (Include COVID-19) Business (2020-2025)
 Figure 58. Merck Revenue Growth Rate in Vaccine (Include COVID-19) Business (2020-2025)
 Figure 59. Sinovac Revenue Growth Rate in Vaccine (Include COVID-19) Business (2020-2025)
 Figure 60. Zhejiang Pukang Revenue Growth Rate in Vaccine (Include COVID-19) Business (2020-2025)
 Figure 61. Walvax Biotechnology Revenue Growth Rate in Vaccine (Include COVID-19) Business (2020-2025)
 Figure 62. Bharat Biotech Revenue Growth Rate in Vaccine (Include COVID-19) Business (2020-2025)
 Figure 63. Serum Institute Revenue Growth Rate in Vaccine (Include COVID-19) Business (2020-2025)
 Figure 64. Panacea Biotec Ltd Revenue Growth Rate in Vaccine (Include COVID-19) Business (2020-2025)
 Figure 65. Bio-Med Revenue Growth Rate in Vaccine (Include COVID-19) Business (2020-2025)
 Figure 66. Halfkin Bio-Pharmaceuticals Revenue Growth Rate in Vaccine (Include COVID-19) Business (2020-2025)
 Figure 67. LG Life Sciences Revenue Growth Rate in Vaccine (Include COVID-19) Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Travelers Vaccination Market Research Report 2025
Global Travelers Vaccines Market Research Report 2025
Global Human Vaccination Market Research Report 2025
Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Dog Vaccines Market Insights Forecast to 2030
Global Cat Vaccines Market Insights Forecast to 2030
Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Farm Animal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Veterinary Biological Vaccines Market Research Report 2025
Global Veterinary Vaccination Market Research Report 2025
mRNA COVID 19 Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Veterinary Vaccine Adjuvants Market
Veterinary Vaccine Market
Animal Vaccine Adjuvant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biological Vaccines Adjuvants Market Research Report 2025
Global Nucleic Vaccine Market Insights Forecast to 2030
Global Covid 19 Vaccine Market Research Report 2024
Global Livestock Animal Vaccines Market Research Report 2024
Global Ebola Virus Vaccine Market Research Report 2025
Ruminant Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions